Core Laboratories (NYSE:CLB) Announces Earnings Results, Beats Estimates By $0.03 EPS

Core Laboratories (NYSE:CLB) posted its quarterly earnings results on Wednesday. The oil and gas company reported $0.11 EPS for the quarter, beating analysts’ consensus estimates of $0.08 by $0.03, FiscalAI reports. Core Laboratories had a return on equity of 11.52% and a net margin of 5.94%.The business had revenue of $124.61 million during the quarter, compared to the consensus estimate of $126.26 million. During the same quarter in the previous year, the firm earned $0.19 earnings per share. Core Laboratories’s revenue for the quarter was down 4.3% compared to the same quarter last year. Core Laboratories updated its Q3 2026 guidance to 0.120-0.200 EPS.

Core Laboratories Price Performance

Shares of Core Laboratories stock traded up $0.37 during midday trading on Thursday, hitting $10.24. 238,339 shares of the company traded hands, compared to its average volume of 587,162. The stock has a market cap of $471.97 million, a price-to-earnings ratio of 15.74, a PEG ratio of 2.58 and a beta of 1.00. The company has a debt-to-equity ratio of 0.42, a quick ratio of 1.50 and a current ratio of 2.05. The firm’s fifty day moving average price is $12.17 and its 200-day moving average price is $15.32. Core Laboratories has a 12 month low of $9.72 and a 12 month high of $20.36.

Core Laboratories Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Monday, August 31st. Stockholders of record on Monday, August 10th will be paid a $0.01 dividend. This represents a $0.04 dividend on an annualized basis and a dividend yield of 0.4%. The ex-dividend date is Monday, August 10th. Core Laboratories’s dividend payout ratio (DPR) is presently 6.15%.

Analyst Upgrades and Downgrades

Several equities analysts have recently commented on the stock. Wall Street Zen cut shares of Core Laboratories from a “hold” rating to a “sell” rating in a research report on Saturday, July 4th. Weiss Ratings downgraded shares of Core Laboratories from a “hold (c-)” rating to a “sell (d+)” rating in a report on Wednesday, June 24th. One equities research analyst has rated the stock with a Hold rating and one has given a Sell rating to the company. According to MarketBeat.com, the company has an average rating of “Reduce”.

Hedge Funds Weigh In On Core Laboratories

Institutional investors and hedge funds have recently added to or reduced their stakes in the stock. Aster Capital Management DIFC Ltd bought a new stake in shares of Core Laboratories during the fourth quarter worth $34,000. Quarry LP lifted its stake in shares of Core Laboratories by 118.1% in the 3rd quarter. Quarry LP now owns 2,953 shares of the oil and gas company’s stock valued at $36,000 after acquiring an additional 1,599 shares during the last quarter. Tower Research Capital LLC TRC lifted its stake in shares of Core Laboratories by 400.9% in the 2nd quarter. Tower Research Capital LLC TRC now owns 7,333 shares of the oil and gas company’s stock valued at $84,000 after acquiring an additional 5,869 shares during the last quarter. Vestcor Inc bought a new position in shares of Core Laboratories in the 3rd quarter valued at $101,000. Finally, Mercer Global Advisors Inc. ADV acquired a new stake in shares of Core Laboratories during the 3rd quarter valued at $132,000. Institutional investors own 97.81% of the company’s stock.

Core Laboratories Company Profile

Core Laboratories N.V. is a global provider of proprietary and patented reservoir description and production enhancement services to the oil and gas industry. The company applies specialized expertise in core and fluid analysis, advanced petrophysical interpretation, and reservoir engineering to optimize hydrocarbon recovery. By integrating laboratory testing with field services and digital analytics, Core Laboratories delivers insights that help operators maximize production and extend the life of their assets.

The company’s portfolio spans two primary service lines: reservoir description and production enhancement.